CHRS vs AMGN: Which Stock is Better?
Side-by-side comparison of Coherus BioSciences Inc and Amgen Inc in 2026
CHRS
Coherus BioSciences Inc
—
AMGN
Amgen Inc
$368.10
Key Metrics Comparison
| Metric | CHRS | AMGN | Winner |
|---|---|---|---|
| Market Cap | $223.66M | $188.67B | AMGN |
| P/E Ratio | N/A | 24.33 | AMGN |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze CHRS
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CHRS or AMGN a better investment?
Comparing CHRS and AMGN: Coherus BioSciences Inc has a market cap of $223.66M while Amgen Inc has $188.67B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CHRS and AMGN?
CHRS (Coherus BioSciences Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CHRS or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CHRS or AMGN?
Both CHRS and AMGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: CHRS or AMGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: CHRS or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $188.67B compared to $223.66M for CHRS.
Should I buy CHRS or AMGN in 2026?
Both CHRS and AMGN have investment merit. CHRS trades at $N/A while AMGN trades at $368.10. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CHRS and AMGN stock?
Key differences: Market Cap ($223.66M vs $188.67B), P/E Ratio (N/A vs 24.3x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy CHRS or AMGN in 2026?
The choice between CHRS and AMGN depends on your investment goals. AMGN shows higher revenue growth (0.0%). AMGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between CHRS and AMGN?
CHRS (Coherus BioSciences Inc) has a market cap of $223.66M, while AMGN (Amgen Inc) has a market cap of $188.67B. AMGN is the larger company by market value.